Outpace Bio
PrivateLast Round
Series B
Aug 1, 2024
Total Funding Raised
$174M
Company Overview
Outpace Bio is a biotechnology company that develops AI-powered protein design technologies to engineer immune cells for more effective and safer cell therapies targeting solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Outpace Bio Comparables
Compare Outpace Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ArsenalBio | 78% | |
| LabGenius Therapeutics | 74% | |
| Evozyne | 73% | |
Outpace Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 1, 2024 | ||||
| Series A | Mar 31, 2021 |
Key People
Founding team and executive leadership
Outpace Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surveyor Capital | Series B |
| RA Capital Management | Series B |
| WRF Capital | Series A, Series B |
| Playground Global | Series A, Series B |
| ARTIS Ventures | Series B, Series A |
| Washington Research Foundation Capital | Series A, Series B |
| Abstract Ventures | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 4, 2025
Lead candidate OPB-101 targeting ovarian cancer to begin dosing in 2025.
- Aug 1, 2024
$144M round led by RA Capital Management.
Outpace Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Outpace Bio's valuation, stock price, and market status.